Jan 19, 2013 - 6:53 pm
John had his 36 week scan on Wednesday, January 16. Scan basically showed stability since last scan. But the report came with an initial gasp as his nurse noted what she considered good news: “John’s liver tumor had decreased in size.” That wasn’t particularly well received as John didn’t know he had a liver tumor. After John questioned this, Dr. Hammers confirmed his belief there is no liver tumor and that the radiologist’s comment on the report was not a cause for worry.
Overall, John and I are extremely happy that he continues positive results from the Nivolumab/Votrient trial. John hasn’t posted these results as I believe he’s experiencing a little guilt. Keeps asking why he continues to get positive results when so many aren’t as fortunate.?.?
MEDSCAN MAN – hope you are around to comment and make sense of the liver question. This is what is noted: “Abdomen: In the arterial phase inferiorly in hepatic segment 6/7 a 4.7 mm enhancing lesion has been decreased since prior studies measuring 8.8 mm on the study of 8/1/2012.”
John’s History at Johns Hopkins:
10/14/11 – Diagnosed with Kidney cancer clear cell/grade 4/stage 4 – with sarcomatoid features and lung mets; also has soft tissue mass in shoulder area and pelvic area.
Symptoms: weight loss followed by cough
Treatments to date:
5/10/2012 – Began Nivolumab/Votrient trial BMS 936558 (also began Xgeva);
10/24/2012-CT scan showed 47% reduction (1% add’l.)